| NCT04271280 |
Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events |
https://ClinicalTrials.gov/show/NCT04271280 |
Recruiting |
Daiichi Sankyo, Inc. |
2021-12-31 |
| NCT03379558 |
Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study |
https://ClinicalTrials.gov/show/NCT03379558 |
Active, not recruiting |
Sanofi |
2028-09-30 |
| NCT03394859 |
Electronic Medical Records and Genomics (eMERGE) Phase III |
https://ClinicalTrials.gov/show/NCT03394859 |
Completed |
Vanderbilt University Medical Center |
2020-04-01 |
| NCT03253432 |
IN-TANDEM Familial Hypercholesterolemia Pilot Study |
https://ClinicalTrials.gov/show/NCT03253432 |
Completed |
University of Pennsylvania |
2018-11-07 |
| NCT03198897 |
Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH) |
https://ClinicalTrials.gov/show/NCT03198897 |
Active, not recruiting |
Centogene AG Rostock |
2021-06-30 |
| NCT03110250 |
Familial Hypercholesterolemia in Turkey (A-HIT2) |
https://ClinicalTrials.gov/show/NCT03110250 |
Completed |
Ege University |
2017-11-30 |
| NCT03018678 |
Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT03018678 |
Completed |
University of Pennsylvania |
2017-05-30 |
| NCT02976818 |
Lp(a) and Aortic Valve Calcification |
https://ClinicalTrials.gov/show/NCT02976818 |
Completed |
Laval University |
2019-10-31 |
| NCT02906124 |
Study to Evaluate the Safety of Repatha® in Pregnancy |
https://ClinicalTrials.gov/show/NCT02906124 |
Recruiting |
Amgen |
2026-06-19 |
| NCT02808403 |
Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan |
https://ClinicalTrials.gov/show/NCT02808403 |
Recruiting |
Amgen |
2022-04-30 |
| NCT02770131 |
Chart Review of Repatha® in Subjects With Hyperlipidaemia |
https://ClinicalTrials.gov/show/NCT02770131 |
Recruiting |
Amgen |
2021-06-24 |
| NCT02750527 |
Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany |
https://ClinicalTrials.gov/show/NCT02750527 |
Enrolling by invitation |
Kinderkrankenhaus auf der Bult |
2020-12-31 |
| NCT02721992 |
Graves’ Orbitopathy and Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT02721992 |
Completed |
University of Pisa |
2017-06-30 |
| NCT02694094 |
Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy |
https://ClinicalTrials.gov/show/NCT02694094 |
Enrolling by invitation |
Johns Hopkins University |
2022-12-31 |
| NCT02693548 |
The Spanish Familial Hypercholesterolaemia Cohort Study |
https://ClinicalTrials.gov/show/NCT02693548 |
Recruiting |
Fundación Hipercolesterolemia Familiar |
2020-10-31 |
| NCT00001154 |
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins |
https://ClinicalTrials.gov/show/NCT00001154 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02523001 |
Effect of Statin Treatment on Urinary AQP2 (uAQP2/01) |
https://ClinicalTrials.gov/show/NCT02523001 |
Completed |
University of Bari |
2014-05-31 |
| NCT02518516 |
High Potency Statins and Acute Kidney Injury |
https://ClinicalTrials.gov/show/NCT02518516 |
Completed |
Canadian Network for Observational Drug Effect Studies, CNODES |
2013-01-31 |
| NCT02392416 |
Atorvastatin Study in Cardiovascular Disease Risk |
https://ClinicalTrials.gov/show/NCT02392416 |
Completed |
Elpen Pharmaceutical Co. Inc. |
2016-02-29 |
| NCT02286596 |
Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT02286596 |
Completed |
Laval University |
2013-06-30 |
| NCT02230241 |
CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II) |
https://ClinicalTrials.gov/show/NCT02230241 |
Completed |
AstraZeneca |
2015-11-30 |
| NCT02225340 |
Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT02225340 |
Completed |
Laval University |
2014-04-30 |
| NCT01878604 |
Gene Analysis and Treatment Optimization in Chinese Homozygous Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01878604 |
Completed |
Central South University |
2014-10-31 |
| NCT01768403 |
Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01768403 |
Completed |
AstraZeneca |
2011-03-31 |
| NCT01753232 |
Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter |
https://ClinicalTrials.gov/show/NCT01753232 |
Completed |
Fresenius Medical Care Deutschland GmbH |
2014-12-31 |
| NCT01678521 |
Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients |
https://ClinicalTrials.gov/show/NCT01678521 |
Completed |
Universita di Verona |
2013-12-31 |
| NCT01625884 |
Observational Study to Understand Patients’ and Physicians’ Attitudes to Statins in TurkeY |
https://ClinicalTrials.gov/show/NCT01625884 |
Completed |
AstraZeneca |
2012-12-31 |
| NCT01614561 |
An Observational Study Evaluating Cholesterol Levels in Patients on Cholesterol Lowering Drugs in Jordan and Lebanon |
https://ClinicalTrials.gov/show/NCT01614561 |
Completed |
AstraZeneca |
2010-12-31 |
| NCT01604733 |
Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01604733 |
Completed |
AstraZeneca |
2011-06-30 |
| NCT01575171 |
Using Nudges to Implement Comparative Effectiveness |
https://ClinicalTrials.gov/show/NCT01575171 |
Completed |
NYU Langone Health |
2015-05-31 |
| NCT01569867 |
Genetic Influence on Statin Pharmacokinetics |
https://ClinicalTrials.gov/show/NCT01569867 |
Recruiting |
Ohio State University |
2020-06-30 |
| NCT01483950 |
Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values |
https://ClinicalTrials.gov/show/NCT01483950 |
Completed |
AstraZeneca |
2013-01-31 |
| NCT01477944 |
Pattern of Statins Use in Catalonia |
https://ClinicalTrials.gov/show/NCT01477944 |
Completed |
AstraZeneca |
2012-02-29 |
| NCT01446679 |
Special Drug Use-Results Survey of Lipitor Tablets |
https://ClinicalTrials.gov/show/NCT01446679 |
Completed |
Astellas Pharma Inc |
2012-03-31 |
| NCT01414192 |
A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204) |
https://ClinicalTrials.gov/show/NCT01414192 |
Completed |
Merck Sharp & Dohme Corp. |
2014-09-15 |
| NCT01381679 |
Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1) |
https://ClinicalTrials.gov/show/NCT01381679 |
Completed |
Merck Sharp & Dohme Corp. |
2010-12-31 |
| NCT01352897 |
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia |
https://ClinicalTrials.gov/show/NCT01352897 |
Completed |
AstraZeneca |
2010-12-31 |
| NCT04433429 |
Nutraceuticals and Vascular Remodelling |
https://ClinicalTrials.gov/show/NCT04433429 |
Completed |
University of Padova |
2017-12-31 |
| NCT04402112 |
Efficacy and Safety of Pitavastatin in a Real-world Setting |
https://ClinicalTrials.gov/show/NCT04402112 |
Completed |
JW Pharmaceutical |
2017-04-01 |
| NCT04370899 |
Early Detection of Familial Hypercholesterolemia in Children |
https://ClinicalTrials.gov/show/NCT04370899 |
Recruiting |
Institut Investigacio Sanitaria Pere Virgili |
2023-03-14 |
| NCT04319081 |
Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors |
https://ClinicalTrials.gov/show/NCT04319081 |
Recruiting |
Hospital Clinico Universitario de Santiago |
2022-05-01 |
| NCT04317690 |
Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey |
https://ClinicalTrials.gov/show/NCT04317690 |
Enrolling by invitation |
Massachusetts General Hospital |
2020-04-30 |
| NCT04313270 |
Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab® |
https://ClinicalTrials.gov/show/NCT04313270 |
Recruiting |
Federico II University |
2022-12-01 |
| NCT04270344 |
The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment |
https://ClinicalTrials.gov/show/NCT04270344 |
Recruiting |
JW Pharmaceutical |
2020-12-31 |
| NCT04148339 |
A Pilot Study to Explore the Role of Gut Flora in Elevated Cholesterol |
https://ClinicalTrials.gov/show/NCT04148339 |
Recruiting |
ProgenaBiome |
2023-03-31 |
| NCT04148001 |
Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients |
https://ClinicalTrials.gov/show/NCT04148001 |
Active, not recruiting |
Regenxbio Inc. |
2020-12-30 |
| NCT04080050 |
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501 |
https://ClinicalTrials.gov/show/NCT04080050 |
Enrolling by invitation |
Regenxbio Inc. |
2024-09-29 |
| NCT03856476 |
The Effect of Childhood Dyslipidemia on Endothelial and Renal Function |
https://ClinicalTrials.gov/show/NCT03856476 |
Recruiting |
University of Ioannina |
2020-04-03 |
| NCT03640234 |
Return of Actionable Variants Empirical Study |
https://ClinicalTrials.gov/show/NCT03640234 |
Enrolling by invitation |
Mayo Clinic |
2020-06-30 |
| NCT03631238 |
The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions |
https://ClinicalTrials.gov/show/NCT03631238 |
Completed |
Assiut University |
2018-06-01 |
| NCT03597958 |
Genetic Causes of Hypercholesterolaemia in the Emirati Population |
https://ClinicalTrials.gov/show/NCT03597958 |
Recruiting |
Imperial College London Diabetes Centre |
2020-12-31 |
| NCT03520140 |
Prevalence of Familial Hypercholesterolaemia (FH) in Italian Patients With Coronary Artery Disease |
https://ClinicalTrials.gov/show/NCT03520140 |
Completed |
Heart Care Foundation |
2018-05-30 |
| NCT03516955 |
Efficacy and Safety of a Generic Rosuvastatin in a Real-world Setting |
https://ClinicalTrials.gov/show/NCT03516955 |
Completed |
Hikma Pharmaceuticals LLC |
2015-08-31 |
| NCT01257971 |
Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors |
https://ClinicalTrials.gov/show/NCT01257971 |
Completed |
AstraZeneca |
2011-10-31 |
| NCT01245738 |
Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204) |
https://ClinicalTrials.gov/show/NCT01245738 |
Completed |
Merck Sharp & Dohme Corp. |
2012-12-31 |
| NCT01243255 |
Polish Survey on the Efficacy of the Hypercholesterolemia Treatment |
https://ClinicalTrials.gov/show/NCT01243255 |
Completed |
AstraZeneca |
2011-06-30 |
| NCT01242319 |
Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice |
https://ClinicalTrials.gov/show/NCT01242319 |
Completed |
Memorial Hospital of Rhode Island |
2008-08-31 |
| NCT01222182 |
Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA) |
https://ClinicalTrials.gov/show/NCT01222182 |
Completed |
Mayo Clinic |
2011-02-28 |
| NCT01221584 |
Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01221584 |
Completed |
AstraZeneca |
2011-03-31 |
| NCT01206231 |
An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01206231 |
Completed |
AstraZeneca |
2011-10-31 |
| NCT01138371 |
Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers |
https://ClinicalTrials.gov/show/NCT01138371 |
Completed |
Emory University |
2012-02-29 |
| NCT01117831 |
An Analysis of Diabetes Control in Puerto Rico |
https://ClinicalTrials.gov/show/NCT01117831 |
Completed |
Center for Diabetes Control, Inc. |
2012-11-30 |
| NCT01109368 |
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository |
https://ClinicalTrials.gov/show/NCT01109368 |
Recruiting |
The Rogosin Institute |
2025-05-31 |
| NCT01107743 |
Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) |
https://ClinicalTrials.gov/show/NCT01107743 |
Completed |
Pfizer |
2012-04-30 |
| NCT01070966 |
Vytorin Reexamination Study (0653A-174) |
https://ClinicalTrials.gov/show/NCT01070966 |
Completed |
Merck Sharp & Dohme Corp. |
2010-04-30 |
| NCT01070953 |
EZETROL® Re-examination Study (MK0653-175)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT01070953 |
Completed |
Merck Sharp & Dohme Corp. |
2010-07-31 |
| NCT01031277 |
Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States |
https://ClinicalTrials.gov/show/NCT01031277 |
Completed |
AstraZeneca |
2010-07-31 |
| NCT01027624 |
Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia |
https://ClinicalTrials.gov/show/NCT01027624 |
Completed |
AstraZeneca |
2010-04-30 |
| NCT01025388 |
Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01025388 |
Completed |
AstraZeneca |
2010-05-31 |
| NCT01011127 |
Different Metabolic Effects of Statins |
https://ClinicalTrials.gov/show/NCT01011127 |
Completed |
Gachon University Gil Medical Center |
2010-07-31 |
| NCT00909389 |
Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients (Study P05647) |
https://ClinicalTrials.gov/show/NCT00909389 |
Completed |
Merck Sharp & Dohme Corp. |
2008-11-30 |
| NCT00848276 |
Sex Hormones and Blood PCSK9 Levels |
https://ClinicalTrials.gov/show/NCT00848276 |
Completed |
Ottawa Hospital Research Institute |
2010-09-30 |
| NCT00837083 |
Evaluation of Crestor® (Rosuvastatin) in Daily Practice |
https://ClinicalTrials.gov/show/NCT00837083 |
Completed |
AstraZeneca |
NA |
| NCT04101149 |
Genetic Causes of Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT04101149 |
Recruiting |
Region Örebro County |
2025-12-31 |
| NCT04133805 |
The Effect of Viscous Dietary Fibers on LDL-cholesterol |
https://ClinicalTrials.gov/show/NCT04133805 |
Active, not recruiting |
St. Michael’s Hospital, Toronto |
2019-12-31 |
| NCT00730132 |
Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <> (Study P05464) |
https://ClinicalTrials.gov/show/NCT00730132 |
Completed |
Merck Sharp & Dohme Corp. |
2009-08-31 |
| NCT00724477 |
Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00724477 |
Completed |
Merck Sharp & Dohme Corp. |
2008-08-31 |
| NCT00723723 |
Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00723723 |
Completed |
Merck Sharp & Dohme Corp. |
2009-06-30 |
| NCT00705211 |
A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245) |
https://ClinicalTrials.gov/show/NCT00705211 |
Completed |
Merck Sharp & Dohme Corp. |
2009-12-31 |
| NCT00705081 |
Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00705081 |
Completed |
Merck Sharp & Dohme Corp. |
2007-12-31 |
| NCT00704535 |
Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00704535 |
Completed |
Merck Sharp & Dohme Corp. |
2008-04-30 |
| NCT00704444 |
A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244) |
https://ClinicalTrials.gov/show/NCT00704444 |
Completed |
Merck Sharp & Dohme Corp. |
2009-09-30 |
| NCT00695539 |
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients |
https://ClinicalTrials.gov/show/NCT00695539 |
Completed |
AstraZeneca |
NA |
| NCT00688454 |
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients |
https://ClinicalTrials.gov/show/NCT00688454 |
Completed |
AstraZeneca |
NA |
| NCT00687492 |
Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00687492 |
Completed |
AstraZeneca |
2008-12-31 |
| NCT00660764 |
Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS) |
https://ClinicalTrials.gov/show/NCT00660764 |
Completed |
AstraZeneca |
NA |
| NCT00574782 |
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE) |
https://ClinicalTrials.gov/show/NCT00574782 |
Completed |
AstraZeneca |
NA |
| NCT00546559 |
Differential Metabolic Effects of Statins |
https://ClinicalTrials.gov/show/NCT00546559 |
Completed |
Gachon University Gil Medical Center |
NA |
| NCT00546182 |
Simvastatin Reduces Adiponectin Levels and Insulin Sensitivity |
https://ClinicalTrials.gov/show/NCT00546182 |
Completed |
Gachon University Gil Medical Center |
NA |
| NCT00542867 |
Pan-European Survey on the Under Treatment of Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00542867 |
Completed |
AstraZeneca |
NA |
| NCT00526721 |
Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION |
https://ClinicalTrials.gov/show/NCT00526721 |
Completed |
AstraZeneca |
2008-04-30 |
| NCT00523796 |
InPractice Survey on the Treatment of Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00523796 |
Completed |
AstraZeneca |
2007-11-30 |
| NCT00388180 |
An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation |
https://ClinicalTrials.gov/show/NCT00388180 |
Completed |
GlaxoSmithKline |
NA |
| NCT00353782 |
Causes and Natural History of Dyslipidemias |
https://ClinicalTrials.gov/show/NCT00353782 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00347217 |
Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event |
https://ClinicalTrials.gov/show/NCT00347217 |
Completed |
AstraZeneca |
NA |
| NCT00240344 |
Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal |
https://ClinicalTrials.gov/show/NCT00240344 |
Completed |
AstraZeneca |
2008-02-29 |
| NCT00115232 |
Inflammatory Profiles of Children at High Risk for Atherosclerosis |
https://ClinicalTrials.gov/show/NCT00115232 |
Completed |
Boston Children’s Hospital |
2006-10-31 |
| NCT00114491 |
Rosuvastatin Affecting Aortic Valve Endothelium |
https://ClinicalTrials.gov/show/NCT00114491 |
Completed |
Hospital Pedro Hispano |
NA |
| NCT00067587 |
Metabolic Abnormalities in HIV Infected and Uninfected Young Women |
https://ClinicalTrials.gov/show/NCT00067587 |
Completed |
University of North Carolina, Chapel Hill |
2005-06-30 |
| NCT00006071 |
Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High Cholesterol |
https://ClinicalTrials.gov/show/NCT00006071 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001742 |
The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic Patients |
https://ClinicalTrials.gov/show/NCT00001742 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00037401 |
Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD |
https://ClinicalTrials.gov/show/NCT00037401 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2005-08-31 |
| NCT00396110 |
Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET) |
https://ClinicalTrials.gov/show/NCT00396110 |
Completed |
AstraZeneca |
NA |
| NCT00005718 |
Evaluation of Cholesterol Education for At-Risk Children |
https://ClinicalTrials.gov/show/NCT00005718 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005694 |
Worksites, Occupational Nurses and Cholesterol Change |
https://ClinicalTrials.gov/show/NCT00005694 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005495 |
Primary Prevention of CHD Risk Factors Occurring in US |
https://ClinicalTrials.gov/show/NCT00005495 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005478 |
Precursors of CVD Risk Factors–Project Heartbeat |
https://ClinicalTrials.gov/show/NCT00005478 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005468 |
Lipid Variability–Influence of Stress |
https://ClinicalTrials.gov/show/NCT00005468 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005463 |
Population-Based Modeling of Cholesterol Lowering in the United States |
https://ClinicalTrials.gov/show/NCT00005463 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005439 |
Evaluation of Childhood Blood Pressure and Lipid Screening |
https://ClinicalTrials.gov/show/NCT00005439 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005350 |
Evaluating Strategies to Control Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00005350 |
Completed |
National Bureau of Economic Research, Inc. |
NA |
| NCT00005336 |
Dietary Treatment of Hyperlipidemia in Women vs. Men |
https://ClinicalTrials.gov/show/NCT00005336 |
Completed |
University of Washington |
NA |
| NCT00005313 |
Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00005313 |
Completed |
University of Washington |
2003-03-31 |
| NCT00005257 |
Diet and Plasma Cholesterol - Secular Trend Analysis |
https://ClinicalTrials.gov/show/NCT00005257 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005210 |
Sex Steroids, Obesity and Lipids in Adolescent Females |
https://ClinicalTrials.gov/show/NCT00005210 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005203 |
Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00005203 |
Completed |
University of Washington |
NA |
| NCT00005178 |
Study of Children’s Activity and Nutrition (SCAN) |
https://ClinicalTrials.gov/show/NCT00005178 |
Completed |
Augusta University |
NA |
| NCT00005168 |
Hyperapo B and Coronary Heart Disease |
https://ClinicalTrials.gov/show/NCT00005168 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005151 |
Pawtucket Heart Health Program |
https://ClinicalTrials.gov/show/NCT00005151 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005134 |
Strong Heart Study |
https://ClinicalTrials.gov/show/NCT00005134 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2005-12-31 |
| NCT00001204 |
Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers |
https://ClinicalTrials.gov/show/NCT00001204 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004481 |
Genetic Study of Sitosterolemia |
https://ClinicalTrials.gov/show/NCT00004481 |
Completed |
National Center for Research Resources (NCRR) |
NA |